Methylprednisolone IP 4mg

CC Pred 4 Tablet is a prescription corticosteroid formulation containing Methylprednisolone IP 4 mg, manufactured by Amista Labs. It is widely used for its potent anti-inflammatory, anti-allergic, and immunosuppressive properties, making it an essential medicine across multiple therapeutic segments such as orthopedics, general practice, dermatology, pulmonology, and autoimmune care.

Methylprednisolone belongs to the class of glucocorticoids, which work by suppressing the immune response and reducing inflammation at the cellular level. CC Pred 4 Tablet is formulated to deliver consistent therapeutic action with high quality standards, ensuring safety, efficacy, and patient compliance.

Composition

Each uncoated tablet contains:
Methylprednisolone IP – 4 mg
Excipients: q.s.

Mechanism of Action

Methylprednisolone acts by inhibiting the release of inflammatory mediators such as prostaglandins, leukotrienes, and cytokines. It reduces capillary permeability, suppresses leukocyte migration, and modulates immune system activity. This results in rapid relief from inflammation, swelling, redness, pain, and allergic manifestations. Due to its immunosuppressive action, it is also effective in autoimmune and post-transplant conditions.

Therapeutic Uses

CC Pred 4 Tablet is indicated in a wide range of medical conditions, including:

• Inflammatory Conditions: Arthritis, bursitis, tendonitis, and other musculoskeletal disorders

• Allergic Reactions: Severe allergies, drug reactions, and hypersensitivity conditions

• Autoimmune Diseases: Rheumatoid arthritis, lupus, and other immune-mediated disorders

• Skin Disorders: Eczema, dermatitis, psoriasis, and inflammatory skin conditions

• Respiratory Disorders: Asthma, COPD exacerbations, and allergic respiratory conditions

• Gastrointestinal Disorders: Inflammatory bowel disease and related conditions

• Endocrine Disorders: Certain adrenal insufficiencies

• Cancer Therapy: As an adjuvant to reduce inflammation and immune reactions

• Post-Transplantation: Prevention and management of organ rejection

Dosage and Administration

The dosage of CC Pred 4 Tablet should be individualized based on the patient’s condition, severity of illness, and clinical response. It must be taken strictly as directed by a registered medical practitioner. Abrupt discontinuation should be avoided, as tapering may be required to prevent withdrawal symptoms.

Safety and Precautions

• CC Pred 4 Tablet should be used with caution in patients with diabetes, hypertension, osteoporosis, infections, or peptic ulcer disease

• Long-term or high-dose usage may lead to immunosuppression or hormonal imbalance

• Regular medical supervision is advised during prolonged therapy

• Not recommended for self-medication

Storage Instructions

Store in a cool and dry place, protected from light and moisture. Keep out of reach of children.

Packaging and Commercial Details

• Category: Ortho / GP

• Strength: Methylprednisolone 4 mg

• Packing: 10 × 10 Tablets (Alu-Alu)

• MRP: ₹ 656.25 per box

• Manufacturer: Amista Labs